FDA Clearance Tracker · K153201
SD GlucoNavii Mentor BT Blood Glucose Monitoring System, SD GlucoNavii Mentor BT Multi Blood Glucose Monitoring System
Last checked: Nov 19, 2026Latest source record: Jun 24, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jun 24, 2016
Substantially Equivalent
Time to decision
233 days
Received Nov 4, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K153201
- Device name
- SD GlucoNavii Mentor BT Blood Glucose Monitoring System, SD GlucoNavii Mentor BT Multi Blood Glucose Monitoring System
- Applicant
- Sd Biosensor
- Applicant location
- Suwon-Si, KR
- Received
- Nov 4, 2015
- Decided
- Jun 24, 2016
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1345
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NBW. The earliest in FDA's data is K010403, decided Mar 26, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K153201
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Sd Biosensor
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K160282 · Decided Oct 17, 2017 · 623 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
- SD GlucoNFC Blood Glucose Monitoring System, SD GlucoNFC Multi Blood Glucose Monitoring System510(k)
K151265 · Decided Nov 24, 2015 · 195 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
K140827 · Decided Sep 30, 2015 · 547 days after receipt
Device type: Assay, Glycosylated Hemoglobin (LCP) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.